New cough combo drug tested in healthy people for first time

NCT ID NCT07161180

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This early-phase trial is testing a new combination drug called PBK_M2301, which contains two ingredients: levodropropizine (a cough suppressant) and Pelargonium sidoides extract (a herbal remedy). The study involves 32 healthy adults aged 19 to 64. Each person will take the combination drug and the two ingredients separately at different times, with a week break in between. The goal is to measure how the drug moves through the body and check for any safety issues.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PBK_M2301 (a tablet combining levodropropizine and Pelargonium sidoides extract)

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • H+ Yangji Hospital

    RECRUITING

    Seoul, Seoul, 08799, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.